
Clinicians have reported cases of pancreatitis, including a fatal case, in patients taking the diabetes and weight loss medication tirzepatide. Healthcare providers should be aware of this potential side effect and closely monitor patients for signs of pancreatitis when prescribing this medication.


coremsg

Researchers reported a case of pancreatitis in two patients taking tirzepatide. The risk for pancreatitis is expected to rise with increased prescriptions of these agents.

Researchers Describe Cases of Pancreatitis With Tirzepatide

fatal-pancreatitis-cases-reported-in-patients-taking-tirzepatide-a-diabetes-and-weight-loss-medication


Fatal Pancreatitis Cases Reported in Patients Taking Tirzepatide, a Diabetes and Weight Loss Medication
